Increased plasma levels of inflammatory markers and upper airway resistance during sleep in pre-eclampsia

Sleep Medicine

Volumn 9, Issue 6, 2008, Pages 667-674

  Bachour, Adel ^a   Teramo, Kari ^a   Hiilesmaa, Vilho ^a   Maasilta, Paula ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Interleukin 6; Pre eclampsia; Pregnancy; Snoring; Tumor necrosis factor alpha; Upper airway resistance

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; INTERLEUKIN 6; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AIRWAY RESISTANCE; ARTICLE; BLOOD OXYGEN TENSION; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; COFFEE; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EDEMA; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; GESTATIONAL AGE; HUMAN; MEDICAL ASSESSMENT; NOSE AIRFLOW; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PULSE OXIMETRY; QUESTIONNAIRE; SLEEP; SLEEP DISORDERED BREATHING; SLEEP WAKING CYCLE; SNORING; SYSTOLIC BLOOD PRESSURE; TEACHING HOSPITAL; TIME; UNIVERSITY HOSPITAL; UPPER RESPIRATORY TRACT;

ADULT; AIRWAY RESISTANCE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; OXIMETRY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48449090744     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.08.007     Document Type: Article

References (48)

1. Edwards N., Middleton P.G., Blyton D.M., and Sullivan C.E. Sleep disordered breathing and pregnancy. Thorax 6 (2002) 555-558
2. Guilleminault C., Querra-Salva M., Chowdhuri S., and Poyares D. Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 1 (2000) 289-292
3. Lee K.A., Zaffke M.E., and McEnany G. Parity and sleep patterns during and after pregnancy. Obstet Gynecol 95 (2000) 14-18
4. The international classification of sleep disorders, revised: diagnostic and coding manual, American Sleep Disorders Association, Rochester, MN; 1997:297-300.
5. Ellegard E.K. Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol 26 (2004) 149-159
6. Guilleminault C., Kreutzer M., and Chang J.L. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 5 (2004) 43-51
7. Walsh S.W. What causes endothelial cell activation in pre-eclamptic women?. Am J Pathol 169 (2006) 1104-1106
8. Mangos G.J. Cardiovascular disease following pre-eclampsia: understanding the mechanisms. J Hypertens 24 (2006) 639-641
9. Izci B., Riha R.L., Martin S.E., Vennelle M., Liston W.A., Dundas K.C., Calder A.A., and Douglas N.J. The upper airway in pregnancy and pre-eclampsia. Am J Respir Crit Care Med 167 (2003) 137-140
10. Edwards N., Blyton D.M., Kirjavainen T., Kesby G.J., and Sullivan C.E. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in pre-eclampsia. Am J Respir Crit Care Med 162 (2000) 252-257
11. Connolly G., Razak A.R., Hayanga A., Russell A., McKenna P., and McNicholas W.T. Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J 18 (2001) 672-676
12. Franklin K.A., Holmgren P.A., Jonsson F., Poromaa N., Stenlund H., and Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 117 (2000) 137-141
13. Di Napoli M., Schwaninger M., Cappelli R., Ceccarelli E., Di Gianfilippo G., Donati C., et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36 (2005) 1316-1329
14. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
15. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
16. Vgontzas A.N., Zoumakis E., Lin H.-M., Vela-Bueno A., and Chrousos P. Marked decrease of sleepiness in patients with sleep apnea by etanercept. J Clin Endocrinol Metab 89 (2004) 4409-4413
17. Maasilta P., Bachour A., Teramo K., Polo O., and Laitinen L.A. Sleep-related disordered breathing during pregnancy in obese women. Chest 120 (2001) 1448-1454
18. Haddad B., Kayem G., Deis S., and Sibai B.M. Are perinatal and maternal outcomes different during expectant management of severe pre-eclampsia in the presence of intrauterine growth restriction?. Am J Obstet Gynecol 196 237 (2007) e1-e5
19. Borgel J., Sanner B.M., Keskin F., Bittlinsky A., Bartels N.K., Buchner N., et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 17 (2004) 1081-1087
20. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183: s1-22.
21. Virkkula P., Bachour A., Hytonen M., Malmberg H., Salmi T., and Maasilta P. Patient- and bed partner-reported symptoms, smoking, and nasal resistance in sleep-disordered breathing. Chest 128 (2005) 2176-2182
22. Rees K., Kingshott R.N., Wraith P.K., and Douglas N.J. Frequency and significance of increased upper airway resistance during sleep. Am J Respir Crit Care Med 162 (2000) 1210-1214
23. Johnson P.L., Edwards N., Burgess K.R., and Sullivan C.E. Detection of increased upper airway resistance during overnight polysomnography. Sleep 28 (2005) 85-90
24. Izci B., Vennelle M., Liston W.A., Dundas K.C., Calder A.A., and Douglas N.J. Sleep-disordered breathing and upper airway size in pregnancy and post-partum. Eur Respir J 27 (2006) 321-327
25. Loube M.D.I., Poceta J.S., Morales M.C., Peacock M.D., and Littner M.M. Self-reported snoring in pregnancy: association with fetal outcome. Chest 109 (1996) 885-889
26. Chiu K.L., Ryan C.M., Shiota S., Ruttanaumpawan P., Arzt M., Haight J.S., et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 174 (2006) 1378-1383
27. Yinon D., Lowenstein L., Suraya S., Beloosesky R., Zmora O., Malhotra A., et al. Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 27 (2006) 328-333
28. Parra O., Garci{dotless}a-Esclasans N., Montserrat J.M., et al. Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies?. Eur Respir J 10 (1997) 1720-1724
29. Luppi P., Tse H., Lain K.Y., Markovic N., Piganelli J.D., and DeLoia J.A. Pre-eclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 56 (2006) 135-144
30. Anim-Nyame N., Sooranna S.R., Jones J., Alaghband-Zadeh J., Steer P.J., and Johnson M.R. Insulin resistance and pre-eclampsia: a role for tumor necrosis factor-alpha?. Gynecol Endocrinol 18 (2004) 117-123
31. Saarela T., Hiltunen M., Helisalmi S., Heinonen S., and Laakso M. Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia. Mol Hum Reprod 11 (2005) 437-440
32. Kaaja R., Kinnunen T., and Luoto R. Regional differences in the prevalence of pre-eclampsia in relation to the risk factors for coronary artery disease in women in Finland. Eur Heart J 26 (2005) 44-50
33. Pouta A., Hartikainen A.L., Sovio U., Gissler M., Laitinen J., McCarthy M.I., et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 43 (2004) 825-831
34. Rosenow F., McCarthy V., and Caruso A.C. Sleep apnoea in endocrine diseases. J Sleep Res 7 (1998) 3-11
35. Walsh S.W. Maternal-placental interactions of oxidative stress and antioxidants in pre-eclampsia. Semin Reprod Endocrin 16 (1998) 93-104
36. Punjabi N.M., and Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 (2007) 29-34
37. Sharma S.K., Mishra H.K., Sharma H., Goel A., Sreenivas V., Gulati V., et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9 2 (2008) 149-156
38. Ryan S., Nolan G., Hannigan E., Cunningham S., Taylor C.T., and McNicholas W.T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62 (2007) 509-514
39. Steiropoulos P., Tsara V., Nena E., Fitili C., Kataropoulou M., Froudarakis M., et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132 (2007) 843-851
40. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
41. Doherty L.S., Kiely J.L., Swan V., and McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127 (2005) 2076-2084
42. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174 (2006) 824-830
43. World Resources Institute. Earth Trends Data Tables: Energy and Resources. Available at: http://earthtrends.wri.org/pdf_library/data_tables/ene5_2005.pdf.
44. Hu G., Jousilahti P., Peltonen M., Bidel S., and Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes 30 (2006) 1742-1749
45. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr (online publication 7 March 2007).
46. Barcelo A., Barbe F., de la Pena M., Vila M., Perez G., Pierola J., et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27 (2006) 756-760
47. Nygård O., Refsum H., Ueland P.M., and Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. Am J Clin Nutr 67 (1998) 263-270
48. El-Khairy L., Vollset S.E., Refsum H., and Ueland P.M. Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study. Am J Clin Nutr 77 (2003) 467-472